View in EDS PDF Full Text

A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma.

Saved in:
Bibliographic Details
Title: A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma.
Authors: Pacey S; Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK., Gore M, Chao D, Banerji U, Larkin J, Sarker S, Owen K, Asad Y, Raynaud F, Walton M, Judson I, Workman P, Eisen T
Source: Investigational new drugs [Invest New Drugs] 2012 Feb; Vol. 30 (1), pp. 341-9. Date of Electronic Publication: 2010 Aug 05.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 20683637
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pacey+S%22">Pacey S</searchLink>; Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK.<br /><searchLink fieldCode="AU" term="%22Gore+M%22">Gore M</searchLink><br /><searchLink fieldCode="AU" term="%22Chao+D%22">Chao D</searchLink><br /><searchLink fieldCode="AU" term="%22Banerji+U%22">Banerji U</searchLink><br /><searchLink fieldCode="AU" term="%22Larkin+J%22">Larkin J</searchLink><br /><searchLink fieldCode="AU" term="%22Sarker+S%22">Sarker S</searchLink><br /><searchLink fieldCode="AU" term="%22Owen+K%22">Owen K</searchLink><br /><searchLink fieldCode="AU" term="%22Asad+Y%22">Asad Y</searchLink><br /><searchLink fieldCode="AU" term="%22Raynaud+F%22">Raynaud F</searchLink><br /><searchLink fieldCode="AU" term="%22Walton+M%22">Walton M</searchLink><br /><searchLink fieldCode="AU" term="%22Judson+I%22">Judson I</searchLink><br /><searchLink fieldCode="AU" term="%22Workman+P%22">Workman P</searchLink><br /><searchLink fieldCode="AU" term="%22Eisen+T%22">Eisen T</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309330%22">Investigational new drugs</searchLink> [Invest New Drugs] 2012 Feb; Vol. 30 (1), pp. 341-9. <i>Date of Electronic Publication: </i>2010 Aug 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309330 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-0646 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676997%22">01676997 </searchLink><i>NLM ISO Abbreviation: </i>Invest New Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=20683637
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10637-010-9493-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 341
    Titles:
      – TitleFull: A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pacey S
      – PersonEntity:
          Name:
            NameFull: Gore M
      – PersonEntity:
          Name:
            NameFull: Chao D
      – PersonEntity:
          Name:
            NameFull: Banerji U
      – PersonEntity:
          Name:
            NameFull: Larkin J
      – PersonEntity:
          Name:
            NameFull: Sarker S
      – PersonEntity:
          Name:
            NameFull: Owen K
      – PersonEntity:
          Name:
            NameFull: Asad Y
      – PersonEntity:
          Name:
            NameFull: Raynaud F
      – PersonEntity:
          Name:
            NameFull: Walton M
      – PersonEntity:
          Name:
            NameFull: Judson I
      – PersonEntity:
          Name:
            NameFull: Workman P
      – PersonEntity:
          Name:
            NameFull: Eisen T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2012 Feb
              Type: published
              Y: 2012
          Identifiers:
            – Type: issn-electronic
              Value: 1573-0646
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Investigational new drugs
              Type: main
ResultId 1